Fo-Ti (He Shou Wu) for Cholesterol Management

Research suggests that Fo-Ti (He Shou Wu, Polygonum multiflorum) and its primary bioactive compound TSG (2,3,5,4'-tetrahydroxystilbene-2-O-β-D-glucoside) may have lipid-lowering and cardiovascular-protective properties, with multiple reviews indicating potential benefits for cholesterol management, atherosclerosis, and hepatic steatosis through mechanisms involving antioxidant activity, reduced inflammation, and improved lipid metabolism. The available evidence comes entirely from reviews and systematic reviews of preclinical and traditional use data, with no randomized controlled trials or clinical studies directly evaluating Fo-Ti for cholesterol outcomes in the linked literature, which substantially limits the strength of conclusions that can be drawn. Studies indicate that emodin, a constituent shared with rhubarb extracts and also present in He Shou Wu, has shown activity in regulating total cholesterol and triglyceride levels in preclinical models. A significant limitation across the research is that He Shou Wu products carry a well-documented risk of hepatotoxicity, and reviewers consistently note that standardized clinical evidence is still needed before these findings can be translated into practical recommendations.